Literature DB >> 3166884

Superparamagnetic particles as an MRI contrast agent for the gastrointestinal tract.

M Lönnemark1, A Hemmingsson, J Carlsten, A Ericsson, E Holtz, J Klaveness.   

Abstract

Non-biodegradable superparamagnetic particles containing magnetite were evaluated as a potential contrast agent for the gastrointestinal tract. The particles were administered to pigs perorally either suspended in water or mixed with food. The gastrointestinal tract structures were excellently depicted through a lowered signal intensity of their content in both T1 and T2 weighted images. Relatively large volumes with low particle concentration seemed to give a good contrast agent distribution, especially when the administration was extended over a period of time. Problems with artefacts and blurring in the images caused by a too high local concentration of the contrast agent should also be minimized by using low particle concentrations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3166884

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  4 in total

1.  Perflubron as a gastrointestinal MR imaging contrast agent in the pediatric population.

Authors:  G S Bisset; K H Emery; M P Meza; N K Rollins; S Don; J S Shorr
Journal:  Pediatr Radiol       Date:  1996

2.  Magnetic microparticle aggregation for viscosity determination by MR.

Authors:  Rui Hong; Michael J Cima; Ralph Weissleder; Lee Josephson
Journal:  Magn Reson Med       Date:  2008-03       Impact factor: 4.668

3.  Gd-DTPA as an intestinal contrast agent for MR imaging of the lower abdomen: phase III clinical trial.

Authors:  L Vlahos; A Gouliamos; W Clauss; A Kalovidouris; A Athanasopoulou; A Petroulakis; A Hadjiioannou; C Papavasiliou
Journal:  Gastrointest Radiol       Date:  1992

Review 4.  New magnetic resonance imaging techniques for the detection of breast cancer.

Authors:  K Orang-Khadivi; B L Pierce; C M Ollom; L J Floyd; R L Siegle; R F Williams
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.